4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MRG | Ann: Initial Director's Interest Notice | 19/04/18 | 0 | 150 | |||
|
|||||||
| MRG | Ann: PAC Partners AgFood & Life Science Conference Presentation | 17/04/18 | 0 | 210 | |||
|
|||||||
| MRG | Ann: Appointment of new Managing Director and CEO | 17/04/18 | 2 | 869 | |||
|
|||||||
| MRG | Ann: Initial Director's Interest Notice | 04/04/18 | 0 | 280 | |||
|
|||||||
| MRG | Ann: Changes to Board and Management | 03/04/18 | 2 | 1.1K | |||
|
|||||||
| MRG | Ann: Ceasing to be a substantial holder | 03/04/18 | 0 | 195 | |||
|
|||||||
| MRG | Ann: Update on evaluation of non-core assets | 22/03/18 | 2 | 1.0K | |||
|
|||||||
| MRG | MRG selling Mildura vineyard | 18/03/18 | 7 | 2.7K | |||
|
|||||||
See All Discussions
ASX News